ASTANA, Kazakhstan, September 18. Gabidulla Ospankulov, Chairman of the Investment Committee of the Ministry of Foreign Affairs of Kazakhstan, met with Li Shuhe, Chairman of Cheng Tian Runkang Pharmaceutical (China), and discussed the launch of a project for the cultivation and processing of industrial hemp with permissible THC levels in Kazakhstan, Trend reports via Kazakh Invest.
The raw materials obtained are planned to be used for the production of medical drugs, dietary supplements, as well as products for the textile industry. In addition, the investor expressed interest in implementing a project in the meat processing sector.
Ospankulov noted that the development of projects in the pharmaceutical sector and the deep processing of agricultural raw materials align with the priorities of Kazakhstan’s investment policy. He emphasized that the state is ready to provide necessary support, including measures of assistance and coordination with relevant agencies.
In turn, Li Shu-he highlighted that Kazakhstan has favorable conditions for the implementation of projects in the agricultural raw materials processing sector. He noted that the company views Kazakhstan as a strategic partner in Central Asia and is interested in long-term cooperation.
Following the meeting, the parties agreed to continue working on the project parameters and to consider the possibilities for practical implementation on the territory of Kazakhstan.
The Chinese company plans to cultivate industrial hemp with an allowable tetrahydrocannabinol content (no higher than 0.3 percent), which complies with international standards and excludes the psychoactive properties of the plant.
